Automated Breast Ultrasound System Market – Global Segments and Forecasts Up to 2023: Transparency Market Research
Albany, NY — (SBWIRE) — 01/08/2016 — Automated breast ultrasound system (ABUS) is designed to acquire ultrasound images of the breast using a broadband transducer when a mammography is unable to detect the breast abnormalities due to the presences of dense tissue. The transducer is scanned over the whole breast, in an automated fashion, to collect three Dimensional (3D) ultrasound volume data without exposing the patients to the radiations and pain. Ultrasound technique provides images in real-time and often with a video of the human anatomy. The Automated breast ultrasound device uses a fully automated process to capture 3D images using a high frequency broadband transducer. The advantage of automated breast ultrasound system over mammography is that automated breast ultrasound system are capable of flowing fluid monitoring as well as identifying abnormal masses in the flowing fluid. Automated breast ultrasound system costs less than most diagnostic imaging techniques. Moreover, ABUS provides safe breast screening without radiation, compression or discomfort to the patient. Growth of the global automated breast ultrasound system is mainly driven by rising prevalence of breast cancer worldwide, growing radiology market and extensive research and development in the imaging techniques. However, factors such as lack of trained personnel with high technical expertise and inadequate insurance coverage coupled with high prices of ABUS devices and high manufacturing and maintenance costs of equipment and accessories are restraining global automated breast ultrasound system market growth.
The global automated breast ultrasound system market has been segmented on the basis of products, end-user and geography. The products segment is categorized depending on the brands such as Invenia (GE Healthcare, SOFIA (Hitachi ltd.), ACUSON S2000 (Siemens AG) and Sonecine (SoneCine, Inc.). The end-user segment is further sub-segmented into hospitals and diagnostic imaging laboratories. The hospitals segment dominated the global automated breast ultrasound system by end-user in terms of revenue and continue to grow at a steady rate. However, the increasing number of diagnostic imaging laboratories would fuel the growth of the diagnostic imaging laboratories segment.
Geographically, North America held the largest share of the global automated breast ultrasound system market, followed by Europe during the forecast period of 2013-2023. The growth of the North American market is likely to be driven due to extensive advancements in the technological front and major market players located in this region. Moreover, rising prevalence of breast cancer in U.S. would drive the demand for automated breast ultrasound system. The American Cancer Society has estimated that 231,840 women are expected to be diagnosed with breast cancer in the U.S. in 2015 while the International Agency for Research on Cancer has stated that there were 458,337 cases of female breast cancer in Europe in 2013. Europe is the second largest medical device technologies market due to increased geriatric population, rising breast cancer cases and government regulations fueling the market growth. Asia-Pacific is considered as an emerging market owing to the untapped opportunities, advancements in the technology and health care infrastructure and rising awareness about health care advancement. Japan, China and India are the fastest growing economy. Additionally, rising medical tourism in these countries would grow the automated breast ultrasound system in Asia-Pacific. South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to developing medical infrastructure, and high disposable income in these countries.
Some of the key players operating in this market are General Electronic Co., Hitachi Ltd., Siemens AG, and SonoCine, Inc.